World Asset Management’s Takeda Pharmaceutical TAK Stock Holding History

World Asset Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-29,927	Closed	-$454K	–	875
2020 Q1	$454K	Hold	29,927	–	–	0.04%	426
2019 Q4	$590K	Sell	29,927 -7,827	-21%	-$150K	0.03%	545
2019 Q3	$649K	Sell	37,754 -7,517	-17%	-$130K	0.03%	516
2019 Q2	$801K	Sell	45,271 -1,574	-3%	-$28.6K	0.04%	459
2019 Q1	$954K	Buy	46,845 +22,922	+96%	+$461K	0.05%	394
2018 Q4	$402K	Buy	+23,923	New	+$404K	0.02%	642

Other funds holding TAK

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

World Asset Management's TAK Position: Q2 2020 in Review

World Asset Management sold out of Takeda Pharmaceutical (TAK) in Q2 2020, closing a stake of 29,927 shares — an estimated $454K sold.

World Asset Management first reported a position in TAK in Q4 2018 and held it in 6 quarters. The position peaked at $954K in Q1 2019. 309 funds tracked by Wall St. Rank hold TAK as of Q2 2020.

World Asset Management reported no remaining Takeda Pharmaceutical position as of Q2 2020 after selling out during the quarter.
World Asset Management sold 29,927 Takeda Pharmaceutical shares in Q2 2020, an estimated $454K.
World Asset Management first reported a position in Takeda Pharmaceutical in Q4 2018 and held it in 6 quarters.
World Asset Management's Takeda Pharmaceutical position peaked at $954K in Q1 2019.
309 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2020.

Based on World Asset Management's 13F filing for Q2 2020, filed 24 Jul 2020.